Schizophrenia.com
Efficacy and safety of evenamide, a glutamate modulator, added to a second-generation antipsychotic in inadequately/poorly responding patients with chronic schizophrenia:
News
everhopeful
December 22, 2024, 12:41pm
1
5 Likes
Related topics
Topic
Replies
Views
Activity
Evenamide for Negative Symptoms in Schizophrenia - Moves on to Phase 3 Clinical Trials
News
2
2834
November 8, 2017
Novel Antipsychotic 'Encouraging' for Resistant Schizophrenia
News
0
319
January 6, 2023
Newron Presents Encouraging Detailed Results of Its Phase IIa Study with Evenamide in Patients with Schizophrenia
News
10
1011
March 26, 2017
Experimental Add-On Drug Achieves "Striking” Results in Treatment-Resistant Schizophrenia
News
2
395
January 4, 2023
Newron announces encouraging preliminary results of its Phase IIa study with Evenamide in patients with schizophrenia
News
14
1393
January 4, 2017